2022 Citation Impact
1.397 - SNIP (Source Normalized Impact per Paper)
2023 Speed
9 days submission to first editorial decision for all manuscripts (Median)
61 days submission to accept (Median)
2023 Usage
781,593 downloads
260 Altmetric mentions
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
Therapeutic options targeting inflammation in multiple sclerosis (MS) have evolved rapidly for relapsing–remitting MS, whereas few therapies are available for progressive forms of MS, in particular secondary p...